Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients

Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients

Data on deleterious variants in genes other than <i>BRCA1/2</i> remain limited. A retrospective cohort study was performed, including primary OC cases with TruRisk<sup>®</sup> germline gene panel testing between 2011 and 2020. Patients with testing after relapse were excluded...

Full description

Bibliographic Details
Main Authors: Majdi Imterat, Philipp Harter, Kerstin Rhiem, Florian Heitz, Stephanie Schneider, Nicole Concin, Malak Moubarak, Julia Welz, Vasileios Vrentas, Alexander Traut, Eric Hahnen, Rita Schmutzler, Andreas du Bois, Beyhan Ataseven
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
<i>BRCA1/2</i>
<i>RAD51C/D</i>
<i>BRIP1</i>
<i>PALB2</i>
ovarian cancer
survival
Online Access:https://www.mdpi.com/2072-6694/15/9/2534

Similar Items

Similar Items